Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. RINALIX TABLET 2.5 MG [SIN11664P]

RINALIX TABLET 2.5 MG [SIN11664P]

Active ingredients: RINALIX TABLET 2.5 MG

Last updated 26 October 2025

Product Info

RINALIX TABLET 2.5 MG

[SIN11664P]

Product information

Active Ingredient and Strength

INDAPAMIDE - 2.5 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD - MALAYSIA

Registration Number

SIN11664P

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

C03BA11

Indications
Rinalix is indicated for the treatment of essential hypertension, alone or in combination with other antihypertensive drugs.

Dosage and Administration
To be administered orally.
Hypertension: 2.5 mg daily, to be taken in the morning. The action of Indapamide is progressive and the reduction in blood pressure may continue and not reach a maximum until several months after the initiation of therapy. A larger dose than 2.5 mg Indapamide is not recommended as there is no appreciable antihypertensive effect but a diuretic effect may become apparent.

Contraindications
Anuria, stroke, recent cerebrovascular accident, severe hepatic insufficiency, known hypersensitivity to indapamide or to other sulfonamide-derived drugs.